» Articles » PMID: 24841294

Calorie Restriction and Roux-en-Y Gastric Bypass Have Opposing Effects on Circulating FGF21 in Morbidly Obese Subjects

Overview
Specialty Endocrinology
Date 2014 May 21
PMID 24841294
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To study the effect of different weight loss strategies on levels of the metabolic regulator FGF21 in morbidly obese females with normal glucose tolerance (NGT) or type 2 diabetes mellitus (T2DM).

Design: Observational intervention trial.

Patients And Measurements: Weight reduction was achieved by Gastric Banding (GB, n = 11) or Roux-en-Y Gastric Bypass (RYGB, n = 16) in subjects with NGT, and by RYGB (n = 15) or a very-low-calorie diet (VLCD, n = 12) in type 2 diabetics. Fasted and/or postprandial levels of FGF21, FGF19 (an FGF21-related postprandial hormone) and bile salts (implicated in regulation of FGF21 and FGF19 expression) were measured before, and 3 and 12 weeks after intervention.

Results: Fasted FGF21 levels were elevated in T2DM subjects. Calorie restriction by either GB or VLCD lowered bile salt and FGF21 levels. In contrast, RYGB surgery was associated with elevated bile salt and FGF21 levels.

Conclusions: Calorie restriction and RYGB have opposite effects on serum bile salt and FGF21 levels. Calorie restriction results in FGF21 approaching nonobese control levels, suggesting that this intervention is effective in reducing the "nutritional crisis" that appears to underly FGF21 elevation in obesity. FGF21 elevation after RYGB may contribute to the beneficial effect of this procedure.

Citing Articles

Multiomics unravels the complexity of male obesity: a prospective observational study.

Papadakis G, Favre L, Zouaghi Y, Vionnet N, Niederlander N, Adamo M J Transl Med. 2025; 23(1):138.

PMID: 39885510 PMC: 11783726. DOI: 10.1186/s12967-024-06040-7.


FGF21 and its underlying adipose tissue-liver axis inform cardiometabolic burden and improvement in obesity after metabolic surgery.

Patt M, Karkossa I, Krieg L, Massier L, Makki K, Tabei S EBioMedicine. 2024; 110:105458.

PMID: 39608059 PMC: 11638646. DOI: 10.1016/j.ebiom.2024.105458.


Weight-loss maintenance is accompanied by interconnected alterations in circulating FGF21-adiponectin-leptin and bioactive sphingolipids.

Fiorenza M, Checa A, Sandsdal R, Jensen S, Juhl C, Noer M Cell Rep Med. 2024; 5(7):101629.

PMID: 38959886 PMC: 11293340. DOI: 10.1016/j.xcrm.2024.101629.


Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes.

Richter M, Thomsen M, Skytte M, Kjeldsen S, Samkani A, Frystyk J J Endocr Soc. 2024; 8(4):bvae008.

PMID: 38379856 PMC: 10875725. DOI: 10.1210/jendso/bvae008.


3-Month Post-Operative Increase in FGF21 is Predictive of One-Year Weight Loss After Bariatric Surgery.

De Luca A, Delaye J, Fauchier G, Bourbao-Tournois C, Champion H, Bourdon G Obes Surg. 2023; 33(8):2468-2474.

PMID: 37391682 DOI: 10.1007/s11695-023-06702-3.